[Suppression of hydroxyindole-acetic acid excretion in urine after reserpine administration in humans; with special consideration to carcinoid syndrome].
D000085:Acetates; D002276:Carcinoid Tumor / Q000652:urine*; D041981:Gastrointestinal Tract; D006897:Hydroxyindoleacetic Acid; D007210:Indoleacetic Acids / Q000031:analogs & derivatives; D008303:Malignant Carcinoid Syndrome; D009369:Neoplasms; D012110:Reserpine / Q000494:pharmacology*
D000085:Acetates; D007210:Indoleacetic Acids; D006897:Hydroxyindoleacetic Acid; C030737:indoleacetic acid; D012110:Reserpine
ARGENTAFFINOMA/urine in; GASTROINTESTINAL SYSTEM/neoplasms; INDOLACETIC ACID/related compounds; RESERPINE/effects
Uber das Verhalten der Hydroxyindolessigsäure-Ausscheidung im Urin nach Reserpin beim Menschen; mit besonderer Berücksichtigung des Karzinoidsyndroms.